Depressive symptoms associated with premature mortality in type 1 diabetes

June 17, 2014 by Allison Hydzik

(Medical Xpress)—People with type 1 diabetes have a higher risk of premature death as their number of depressive symptoms increases, a University of Pittsburgh Graduate School of Public Health analysis reveals.

The findings were presented in a press conference at the American Diabetes Association's 74th Scientific Sessions in San Francisco and used data collected through the Pittsburgh Epidemiology of Diabetes Complications Study, a long-term study of health complications in people with type 1 diabetes.

"Through the 25 years that we've been running this study, we've found that there's a lot more to diabetes than ," said senior author Trevor Orchard, M.D., professor of epidemiology at Pitt Public Health. "This link between premature mortality and depression adds to our previous findings, which show that depressive symptomatology predicts cardiovascular disease and demonstrates that doctors need to consider more than adjusting insulin doses when treating type 1 diabetes."

Lead author Cassie Fickley, M.P.H., C.P.H., analyzed data on 458 study participants with type 1 diabetes who were assessed using the Beck Depression Inventory, a 32-point scale that measures depressive symptoms ranging from loss of appetite to suicidal tendencies. People who score 16 or more points are considered likely to be clinically depressed.

"For every one-point increase on the scale, participants showed a 4 percent increase in risk for mortality, even after controlling for other relevant factors, such as age, gender, smoking, cholesterol levels and ," said Ms. Fickley, a doctoral student in Pitt Public Health's Department of Epidemiology. "That's a significant increase and is something we'll need to explore more to determine if treating depression would translate into lower mortality in people with type 1 diabetes."

Type 1 diabetes is usually diagnosed in children and young adults and happens when the body does not produce insulin, a hormone that is needed to convert sugar into energy. The disease can lead to nerve, kidney, eye and heart complications but can be controlled with insulin therapy and other treatments.

The Pittsburgh Epidemiology of Diabetes Complications Study is an investigation to document long-term complications of type 1 among patients at Children's Hospital of Pittsburgh between 1950 and 1980. Funded by the National Institutes of Health, the study recently was renewed for another five years.

"It is thanks to the volunteers who participate in this study that we are able to make discoveries like this that will contribute to better therapies and life expectancy for children diagnosed with today and in the future," said Dr. Orchard.

Explore further: Diabetes distress vs. depression: Are people with type 2 being misdiagnosed?

Related Stories

Diabetes distress vs. depression: Are people with type 2 being misdiagnosed?

June 16, 2014
Researchers have long understood there is a strong association between diabetes and depression. But new research presented at the American Diabetes Association's 74th Scientific Sessions shows that symptoms of depression ...

Older age at onset of Type 1 diabetes associated with lower brain connectivity

March 14, 2014
Children and adolescents older than age 8 at the onset of type 1 diabetes had weaker brain connectivity when tested later in life relative to those who had earlier ages of diagnosis, University of Pittsburgh Schools of the ...

Life expectancy for those with Type 1 diabetes improving, study says

June 24, 2011
The life expectancy of people diagnosed with type 1 diabetes dramatically increased during the course of a 30-year, long-term prospective study, according to a University of Pittsburgh Graduate School of Public Health study ...

Diabetes Association sets new A1C target for children with type 1 diabetes

June 16, 2014
According to a new position statement released at the Association's 74th Scientific Sessions, the American Diabetes Association is lowering its target recommendation for blood glucose levels for children with type 1 diabetes, ...

Inflammation tied to depressive symptoms in new T2DM

May 30, 2014
(HealthDay)—For patients with newly diagnosed type 2 diabetes, inflammatory markers are associated with depressive symptoms, according to a study published online May 19 in Diabetes Care.

Depression modifies type A behavior, mortality link in T1DM

August 12, 2013
(HealthDay)—For individuals with type 1 diabetes, type A personality is associated with lower all-cause mortality, with the correlation modified by depressive symptomatology, according to a study published online July 8 ...

Recommended for you

Scientists discover a new way to treat type 2 diabetes

July 21, 2017
Medication currently being used to treat obesity is also proving to have significant health benefits for patients with type 2 diabetes. A new study published today in Molecular Metabolism explains how this therapeutic benefit ...

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.